{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-21-055978","form_type":"8-K","ticker":"FRMM","cik":"0001690080","company_name":"FORUM MARKETS Inc","filed_at":"2021-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.692846+00:00","generated_at":"2026-06-28T15:15:19.237888+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"180 Life Sciences appoints Quan Anh Vu as COO/CBO; salary $390k, 275k option grant","bullets":["Quan Anh Vu appointed COO/CBO effective October 29, 2021; employment agreement dated Oct 27, effective Nov 1, 2021.","Base salary of $390,000 per year, with 5% potential annual increase and $10k bump upon $50M+ financing.","Initial option grant of 275,000 shares vesting monthly over 48 months; immediate vesting on change of control or termination without cause.","Target annual bonus of 50% of base salary based on performance objectives; can be paid in cash or stock.","Severance: 12 months base salary plus pro-rata bonus if terminated without cause or for good reason, subject to release."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-21-055978","json":"https://secwatch.observer/filing/0001213900-21-055978.json","markdown":"https://secwatch.observer/filing/0001213900-21-055978.md","text":"https://secwatch.observer/filing/0001213900-21-055978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021055978/0001213900-21-055978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021055978/ea149725-8k_180life.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T15:15:19.237888+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2d8ff7de31","claim":"Quan Anh Vu was appointed as Chief Operating Officer/Chief Business Officer at FORUM MARKETS Inc.","evidence_excerpt":"Effective on October 29, 2021, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “we” and “us”), appointed Mr. Quan Anh Vu as Chief Operating Officer/Chief Business Officer (“ COO/CBO ”) of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021055978/0001213900-21-055978-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer/Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}